Update in medicine - London 2025

Registered delegates will gain access to the presentations we have been given permission to share.

Please come back soon to view these. 

Vicky Cartwright

Vicky Cartwright is a clinical engagement manager at Alzheimer’s Research UK, where she leads work to connect the clinical community with the charity’s mission. Her work focuses on shaping best practice, supporting the adoption of innovative healthcare models, and helping to ensure that cutting-edge research delivers real-world impact for people affected by dementia. 

Dr Leah Mursaleen

Dr Leah Mursaleen is head of clinical research at Alzheimer’s Research UK. Following her father’s diagnosis with Parkinson’s, she completed her BSc and MRes in neuroscience at the University of Sussex and her PhD at the University of Westminster, in collaboration with the School of Pharmacy at UCL. From 2014-2023, with the research charity Cure Parkinson’s, she worked closely with people living with Parkinson’s, academic researchers, industry, and clinicians to develop and accelerate research focused on slowing, stopping, and reversing Parkinson’s, liaising with other funding bodies and regulatory agencies to understand the hurdles of moving research forward. She is now applying these learnings for dementia research, with the development of Alzheimer’s Research UK’s clinical accelerator programme which aims to accelerate clinical evaluation of potential therapies and bring more clinical trials to the UK for people living with or likely to develop dementia.

Professor Daniel Davis

Daniel is an academic geriatrician at University College London and does both acute and community medicine. He has been involved in delirium research for over 15 years and has a special interest in cognitive outcomes after delirium.

Nadia Persaud

Nadia Persaud qualified as a solicitor in 1995 and completed a master’s degree in medical law and ethics at Kings College London. As a solicitor, she practised medical law which included acting for hospital trusts in clinical negligence claims, inquests, court of protection matters and judicial reviews. Nadia left private practice in 2014 to become a full-time coroner. She currently sits as the area coroner in east London. 

Dr Ruth Williams

Dr Ruth Williams has been a consultant paediatric neurologist at the Evelina London Children’s Hospital since May 2003. She trained in general paediatrics to senior registrar level in a variety of secondary and tertiary level centres in Nottingham, Birmingham, Bath and London, and completed a doctorate in the genetics of a rare neurodegenerative disease affecting children in the early 1990s. 
Ruth went on to complete training in paediatric neurology at Great Ormond Street Hospital for Children. She cares for children with severe and complex epilepsy, seeing children alongside general paediatricians with expertise in epilepsy in regional complex epilepsy clinics. She has led the ketogenic diet service for children with epilepsy at Evelina for the last 20 years. Ruth has a long-term interest in paediatric end of life care, clinical ethics and good communication skills. These, in combination with some Research Ethics Committee experience, prepared her for the role of medical examiner. She trained and was appointed medical examiner in April 2020, as the service at Guy’s and St Thomas was in its infancy, and subsequently took on the role of lead medical examiner for Lambeth and Southwark in May 2024.

Dr Luke Smith FRCP

Dr Luke Smith is a consultant in acute and general medicine with an interest in medical toxicology and medicines safety. He has been providing expert medical witness opinions since 2017.

Dr Kathryn Hawkesford

Dr Kathryn Hawkesford is a consultant medical oncologist specialising in breast cancer at Barts Cancer Centre in London. She completed undergraduate training at Nottingham University and went on to complete specialist training in medical oncology at Barts Cancer Centre in 2020. Kathryn undertook a PhD in breast cancer preventive therapies with QMUL and developed London’s first dedicated breast preventive therapy clinic. She has a specialist interest in medical education and is the medical oncology training programme director and the clinical director for education for cancer services across Barts Health.

Dr Michael-John Devlin

Dr Michael-John Devlin is a medical oncology consultant working in Barts NHS Trust, treating patients with gynaecological and skin malignancies. He is clinical director for acute cancer services across the trust, taking on the acute oncology service, day assessment units and chemotherapy hotline. As an honorary clinical senior lecturer at Queen Mary University London, he is involved in research exploring the links between the immune system and cancer. 

Professor Ketan Dhatariya FRCP

Professor Ketan Dhatariya graduated from the University of London in 1991 and completed his diabetes and endocrinology training in and around London. He was also a part-time general practitioner and took some time out of his training to spend a year doing intensive care medicine and anaesthetics. After finishing training in 2001, he conducted a research fellowship in endocrinology at Mayo Clinic. 
Ketan was appointed as a consultant in diabetes, endocrinology and general medicine at the Norfolk and Norwich University Hospital in 2004, and honorary professor of medicine at the University of East Anglia in 2019. He has several national roles in the UK. He is chair of the Association Of British Clinical Diabetologists and chair of the Examining Board for the UK specialist clinical exam in diabetes and endocrinology. Ketan was also chair of the Joint British Diabetes Societies Inpatient Care Group. He is the section co-editor for diabetes for www.endotext.org and chair of the 2027 International Working Group for the Diabetic Foot Guideline Writing Group for Wound Healing. Ketan has over 225 peer reviewed publications and has published over 25 book chapters on inpatient diabetes, peri-operative diabetes care for the diabetic foot. 

Dr Andrew Frankel FRCP

Dr Andrew Frankel has been working as a consultant nephrologist at Imperial College Healthcare NHS Trust since 1995. He has extensive experience in managing all aspects of kidney disease but has a particular interest in relation to the management of diabetes in the context of kidney disease. Andrew maintained a research interest in relation to diabetes and kidney, both in terms of how diabetes affects the kidneys leading to deterioration in kidney function but also in relation to how the presence of kidney disease influences the management of diabetes. He has led locally, regionally and nationally on the transformation of kidney care for people with early chronic kidney disease. Andrew is published in relation to the assessment of kidney complications in people with diabetes and obesity, and has played a significant role in the development of UK national guidelines in the management of diabetes in the context of kidney disease. He is joint editor of the UK Kidney Association guidelines on the use of SGLT2I in adults with chronic kidney disease and joint editor of the JBDS national guidelines on the management of diabetes in people on dialysis. Andrew is an educational leader supporting the next generation of doctors, having been the director of Imperial’s foundation school from its inception in 2010, the London lead for foundation training from 2010–13 and postgraduate dean for south London from 2013–18.